HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hee Jin Kim Selected Research

Adiponectin

1/2017Polypharmacology of N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic Potential.
1/2009Serum adiponectin is associated with smoking status in healthy Korean men.
1/2009Serum adiponectin is associated with family history of diabetes independently of obesity and insulin resistance in healthy Korean men and women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hee Jin Kim Research Topics

Disease

51Cognitive Dysfunction
07/2022 - 08/2007
47Alzheimer Disease (Alzheimer's Disease)
03/2022 - 08/2007
18Dementia (Dementias)
01/2022 - 08/2007
18Parkinson Disease (Parkinson's Disease)
06/2020 - 09/2009
17Atrophy
01/2021 - 01/2014
12Tuberculosis (Tuberculoses)
01/2020 - 06/2004
11Infections
03/2021 - 09/2003
10Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
03/2022 - 01/2012
10Cerebral Small Vessel Diseases
01/2021 - 02/2015
10Neoplasms (Cancer)
03/2020 - 02/2006
8Stomach Neoplasms (Stomach Cancer)
11/2020 - 08/2008
8Cerebral Cortical Thinning
10/2020 - 01/2015
7Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
12/2020 - 02/2015
6Atopic Dermatitis (Atopic Eczema)
10/2021 - 01/2016
6Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2020 - 11/2013
6Leprosy (Hansen's Disease)
02/2013 - 06/2004
5Inflammation (Inflammations)
06/2018 - 12/2014
5Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2018 - 04/2014
4Dermatitis
07/2022 - 01/2016
4Fever (Fevers)
02/2022 - 09/2003
4Disease Progression
01/2022 - 12/2012
4Pain (Aches)
10/2021 - 04/2010
4Obesity
01/2021 - 01/2009
4Hypertension (High Blood Pressure)
01/2021 - 02/2016
4Latent Tuberculosis
01/2020 - 09/2015
4Mixed Dementias
12/2018 - 01/2013
4Ischemia
01/2018 - 10/2013
3Sleep Initiation and Maintenance Disorders (Insomnia)
02/2022 - 01/2009
3Hemorrhage
01/2022 - 08/2008
3Neuralgia (Stump Neuralgia)
10/2021 - 05/2003
3Dyslipidemias (Dyslipidemia)
01/2021 - 02/2018
3Primary Progressive Aphasia
01/2021 - 01/2016
3Epilepsy (Aura)
03/2020 - 03/2013
3Amyloid Plaque
08/2018 - 01/2013
3Stroke (Strokes)
06/2018 - 02/2016
3Siderosis
01/2018 - 02/2015
3Extensively Drug-Resistant Tuberculosis
06/2017 - 07/2010
3Insulin Resistance
01/2017 - 01/2009
3Adenomyosis
04/2011 - 09/2005
3Leiomyoma (Uterine Fibroids)
02/2010 - 09/2005
2Metaplasia
11/2020 - 10/2015
2Brain Diseases (Brain Disorder)
11/2020 - 03/2020
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2020 - 01/2016
2Alcoholism (Alcohol Abuse)
01/2019 - 10/2012
2Pruritus (Itching)
06/2018 - 01/2016
2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
06/2017 - 02/2016
2Diabetes Mellitus
04/2017 - 02/2016
2Aphasia (Dysphasia)
11/2016 - 01/2016
2Neuroblastoma
10/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

67Amyloid (Amyloid Fibrils)IBA
03/2022 - 01/2013
16Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2009
15Pharmaceutical PreparationsIBA
03/2022 - 09/2003
15Apolipoproteins E (ApoE)IBA
01/2022 - 11/2013
15Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2004
10ApolipoproteinsIBA
01/2022 - 11/2013
105- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA
01/2021 - 05/2013
102- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2018 - 01/2013
8Amyloid beta-PeptidesIBA
01/2022 - 08/2007
77- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
01/2022 - 01/2018
6Methylphenidate (Ritalin)FDA LinkGeneric
03/2022 - 01/2012
6Indicators and Reagents (Reagents)IBA
06/2017 - 12/2005
5Therapeutic UsesIBA
07/2022 - 01/2012
5Apolipoprotein E4IBA
01/2020 - 11/2013
4Retinaldehyde (Retinal)IBA
01/2022 - 01/2019
4Tuberculin (PPD)IBA
10/2019 - 12/2007
4Levodopa (L Dopa)FDA LinkGeneric
01/2019 - 03/2011
4AntigensIBA
08/2014 - 06/2004
3Dopamine (Intropin)FDA LinkGeneric
07/2022 - 09/2009
3Immunoglobulin E (IgE)IBA
07/2022 - 01/2016
3THK5351IBA
03/2022 - 01/2018
3Presenilin-1IBA
01/2021 - 01/2019
3Messenger RNA (mRNA)IBA
11/2020 - 01/2011
34- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA
01/2020 - 01/2018
3Formaldehyde (Formol)FDA Link
01/2017 - 06/2011
3Capsaicin (Zostrix)FDA Link
01/2017 - 01/2016
3AdiponectinIBA
01/2017 - 01/2009
3CytokinesIBA
01/2016 - 09/2008
3Interferon-gamma (Interferon, gamma)IBA
09/2015 - 09/2008
3Scopolamine (Hyoscine)FDA Link
01/2014 - 08/2007
3EnzymesIBA
04/2010 - 06/2007
2Hypnotics and Sedatives (Sedatives)IBA
02/2022 - 01/2009
2Donepezil (Aricept)FDA LinkGeneric
07/2021 - 07/2021
2RNA (Ribonucleic Acid)IBA
03/2021 - 06/2016
2Interleukin-17 (Interleukin 17)IBA
01/2021 - 01/2019
2Biological ProductsIBA
01/2021 - 12/2011
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2021
2GABA AntagonistsIBA
03/2020 - 04/2010
2Rifampin (Rifampicin)FDA LinkGeneric
01/2020 - 03/2010
2GoldIBA
10/2019 - 09/2015
2Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
10/2019 - 01/2017
2Morphine (MS Contin)FDA LinkGeneric
01/2019 - 01/2016
2ChloridesIBA
10/2016 - 01/2015
2Ethanol (Ethyl Alcohol)IBA
05/2016 - 03/2012

Therapy/Procedure

10Therapeutics
10/2021 - 09/2009
10Deep Brain Stimulation
06/2020 - 09/2010
5Uterine Artery Embolization
04/2011 - 09/2005
4Injections
02/2022 - 07/2010
4Activities of Daily Living (ADL)
01/2020 - 03/2011
2Drug Therapy (Chemotherapy)
01/2021 - 07/2011
2Radiotherapy
03/2020 - 11/2010